ReviewBioscience reports2020

Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide.

Abdulla A-B BadawyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.